Get the Stockscreener App
0.8173
4.27%
0.0359
Enlivex Therapeutics Ltd stock is traded at $0.8173, with a volume of 241.26K.
It is up +4.27% in the last 24 hours and down -32.66% over the past month.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
See More
Previous Close:
$0.7814
Open:
$0.7998
24h Volume:
241.26K
Relative Volume:
0.07
Market Cap:
$193.47M
Revenue:
-
Net Income/Loss:
$-14.33M
P/E Ratio:
-1.2383
EPS:
-0.66
Net Cash Flow:
$-13.21M
1W Performance:
+21.25%
1M Performance:
-32.66%
6M Performance:
-30.95%
1Y Performance:
-33.76%
1-Day Range:
$0.76
$0.8215
1-Week Range:
$0.66
$0.8215
52-Week Range:
$0.66
$2.10
Enlivex Therapeutics Ltd Stock (ENLV) Company Profile
Name
Enlivex Therapeutics Ltd
Sector
Industry
Phone
-
Address
-
Compare ENLV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENLV
Enlivex Therapeutics Ltd
|
0.815 | 185.49M | 0 | -14.33M | -13.21M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.00 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
775.08 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
405.94 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.86 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
174.84 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Enlivex Therapeutics Ltd Stock (ENLV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-02-21 | Reiterated | H.C. Wainwright | Buy |
Enlivex Therapeutics Ltd Stock (ENLV) Latest News
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Jackson Sun
Enlivex Therapeutics Ltd. (ENLV) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Rashi Peripherals Limited Stock a Safe LongTerm Investment Data BreakdownSupport Level Holds & Low Cost Capital Trading - earlytimes.in
Free cash flow per share of Enlivex Therapeutics Ltd. – SWB:1BT - TradingView — Track All Markets
Enlivex Therapeutics (NASDAQ:ENLV) Downgraded by Wall Street Zen to “Strong Sell” - Defense World
Energy Moves: Why Enlivex Therapeutics Ltd. stock could outperform in 2025Market Activity Summary & Fast Gain Stock Trading Tips - Улправда
What valuation multiples suggest for Enlivex Therapeutics Ltd. stockQuarterly Portfolio Review & Free Risk Controlled Daily Trade Plans - Улправда
Why Enlivex Therapeutics Ltd. stock could outperform in 2025Chart Signals & Advanced Technical Analysis Signals - Улправда
Why hedge funds are buying Enlivex Therapeutics Ltd. stockMarket Trend Summary & Safe Capital Growth Stock Tips - Улправда
Enlivex Calls February 2026 Extraordinary Meeting to Approve Governance Changes and Reverse Share Split - The Globe and Mail
Levels Update: Will Enlivex Therapeutics Ltd. stock deliver consistent dividendsJuly 2025 Snapshot & Weekly High Return Stock Forecasts - Улправда
Enlivex Therapeutics schedules extraordinary general meeting for February By Investing.com - Investing.com Nigeria
Enlivex Therapeutics schedules extraordinary general meeting for February - Investing.com
Enlivex Therapeutics (NASDAQ: ENLV) schedules Extraordinary General Meeting in Israel - Stock Titan
Earnings Beat: Will Enlivex Therapeutics Ltd. stock deliver consistent dividendsQuarterly Growth Report & Fast Exit and Entry Strategy Plans - Улправда
Enlivex Therapeutics Ltd (ENLV) stock: A year of ups and downs - uspostnews.com
Enlivex Therapeutics (ENLV) price target decreased by 30.00% to 7.14 - MSN
Enlivex: A Necessary UpdateThis Is No Longer The Company We Covered In 2022 (NASDAQ:ENLV) - Seeking Alpha
Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Daily Commercial
An analyst sees good growth prospects for Enlivex Therapeutics Ltd (ENLV) - setenews.com
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Enlivex announces fireside chat on RAIN token and Allocetra development - MSN
Enlivex Announces Fireside Chat on RAIN Token and Allocetra Development - TipRanks
Enlivex Therapeutics Ltd. Announces Virtual Fireside Chat to Discuss Digital Asset Strategy and Clinical Development Plans - Quiver Quantitative
Enlivex Management to Host Fireside Chat on December 11 to Discuss RAIN Token Strategy and Allocetra Clinical Development - marketscreener.com
How Enlivex Therapeutics Ltd. stock reacts to oil pricesTrade Analysis Report & Expert Verified Stock Movement Alerts - Newser
Can Enlivex Therapeutics Ltd. stock sustain revenue growth2025 Stock Rankings & AI Enhanced Execution Alerts - Newser
Is Enlivex Therapeutics Ltd. stock a safe haven asset2025 Stock Rankings & Weekly Setup with ROI Potential - Newser
Enlivex Therapeutics (ENLV) Stock Analysis Report | Financials & Insights - Benzinga
What analysts say about Enlivex Therapeutics Ltd stockTechnical Breakout Signals & Rapid Profit Growth - earlytimes.in
Enlivex Therapeutics (ENLV) to Release Quarterly Earnings on Friday - Defense World
Panic Selling: What margin trends mean for Enlivex Therapeutics Ltd. stock2025 Key Lessons & Verified Chart Pattern Signals - moha.gov.vn
Enlivex Therapeutics Announces Closing of Previously Announced $212,000,000 Private Placement - marketscreener.com
Enlivex Therapeutics Ltd Stock (ENLV) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.45%
0.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):